Melissa D. Hall

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia et al. · Blood · 2004 · 319 citations

Medicine, Oncology, Pharmacology +17

Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation

James Ronald, Qi Wang, Steven S. Choi et al. · Diagnostic and Interventional Imaging · 2017 · 46 citations

Medicine, Surgery, Hepatology +12

Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation

Douglas S. Lewis, Tzu‐Hao Lee, Meghana Konanur et al. · Journal of Vascular and Interventional Radiology · 2019 · 41 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia

Hendrik W. van Deventer, Melissa D. Hall, Robert Z. Orlowski et al. · American Journal of Hematology · 2002 · 10 citations · Full text

Medicine, Hematology, Pharmacology +13